Upload Avatar (500 x 500)
Dedong Cao
Medical School
Wuhan University
Hubei
Language: English, Chinese
Radiotherapy
Sensitization
Mechanisms
Tumor
Metabolism
Immunotherapy
Evidence-Based
Medicine
Oncology
Clinical Trials
Areas of Focus
- Radiotherapy Sensitization Strategies and Mechanisms
- Tumor Metabolism and Immunotherapy
- Evidence-Based Medicine in Oncology
Work Experience
- 2014.07-2014.10 Physician, Oncology Department, Renmin Hospital, Wuhan University
- 2014.11-2017.10 Attending Physician, Oncology Department, Renmin Hospital, Wuhan University
- 2017.11-2018.01 Associate Chief Physician, Oncology Department, Renmin Hospital, Wuhan University
- 2018.02-2019.07 Visiting Scholar, Fred Hutchinson Cancer Research Center, USA
- 2019.08-2020.01 Associate Chief Physician, Oncology Department, Renmin Hospital, Wuhan University
- 2020.02-2020.04 Associate Chief Physician, Fever Clinic and Fever Observation Ward, Renmin Hospital, Wuhan University
- 2020.05-2022.11 Associate Chief Physician, Oncology Department, Renmin Hospital, Wuhan University
- 2022.04-present Deputy Director, Medical Department, Renmin Hospital, Wuhan University
- 2022.11-present Chief Physician, Associate Professor, Oncology Department, Renmin Hospital, Wuhan University
Academic Background & Achievements
- 2004.09-2009.06 Bachelor of Clinical Medicine from Second Clinical College of Yunyang Medical College
- 2009.09-2011.06 Master of Oncology from First Clinical College of Wuhan University
- 2011.09-2014.06 PhD in Internal Medicine from First Clinical College of Tongji Medical College, Huazhong University of Science and Technology
Publications
- The application of nanoparticles in immunotherapy for hepatocellular carcinoma, Hu X, Zhu H, He X, Chen J, Xiong L, Shen Y, Li J, Xu Y, Chen W, Liu X, Cao D, Xu X, 2023
- Tumor-Suppressive and Oncogenic Roles of microRNA-149-5p in Human Cancers, Shen Y, Zhao N, Zhao N, Hu X, He X, Xu Y, Chen J, Chen W, Liu X, Zhou Z, Cao D, Xu X, 2022
- Phagocytosis-Regulators-Based Signature to Predict the Prognosis and Chemotherapy Resistance for Breast Cancer Patients, Feng J, Ren J, Li X, Zhang X, Yang Q, Wu Z, Cui L, Liao L, Gong Y, Cao D, 2022
- The association between antibiotics use and outcome of cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis, Xu H, Xu X, Wang H, Ge W, Cao D, 2020
- High tumor mutation burden predicts better efficacy of immunotherapy: a pooled analysis of 103078 cancer patients, Cao D, Xu H, Xu X, Guo T, Ge W, 2019
- The association between immune-related adverse events and the prognosis of solid cancer patients treated with immunotherapy: a systematic review and meta-analysis, Xu H, Xu X, Ge W, Lei J, Cao D, 2020
- A reliable and feasible way to predict the benefits of Nivolumab in patients with non-small cell lung cancer: a pooled analysis of 14 retrospective studies, D Cao, H Xu, X Xu, T Guo, W Ge, 2018
- The effects of prophylactic cranial irradiation versus control on survival of patients with extensive-stage small-cell lung cancer: a meta-analysis of 14 trials, W Ge, H Xu, Y Yan, D Cao, 2018
- Assessing Potential Factors Influencing the Efficacy of Immune Checkpoint Inhibitors with Radiation in Advanced Non-Small-Cell Lung Cancer Patients: A Systematic Review and Meta-Analysis, Xu H, Cao D, Zhou D, He A, Ge W, Xu X, 2023
- Bevacizumab improves survival in metastatic colorectal cancer patients with primary tumor resection: A meta-analysis, Cao D, Zheng Y, Xu H, Ge W, Xu X, 2019
- The prognostic role of neutrophil-to-lymphocyte ratio and C-reactive protein in metastatic colorectal cancer using regorafenib: a systematic review and meta-analysis, Zhao N, Xu H, Zhou D, Xu X, Ge W, Cao D, 2022
- 胸腔内注射榄香烯治疗肺癌恶性胸腔积液疗效的系统评价, 曹德东,徐敏,蒋振旻,等, 2018
Awards
- Mechanism and Precision Treatment of Primary Liver Cancer, First Prize of Hubei Province Science and Technology Progress Award
- Mechanism and Clinical Application of Recombinant Human Endostatin (Endostar) to Increase Radiotherapy Sensitivity, Third Prize of Hubei Province Science and Technology Progress Award
- Mechanism and Clinical Application of Recombinant Human Endostatin (Endostar) to Increase Radiotherapy Sensitivity, Third Prize of Wuhan Science and Technology Progress Award
